Growth hormone-releasing peptides like sermorelin, promising, especially for specific groups, but more nuanced
BPC-157 is also studied for its interaction with pathways involved in cellular repair and blood flow, which may contribute to its regenerative potential
Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder
10.1016/0006-291X(88)90482-2 Biochem
It supports energy metabolism and may contribute to healthy sperm function
FDA states that ConjuChem Biotechnology withdrew CJC-1295 DAC from clinical trials in 2006 after the death of a subject involved in a phase 2 trial, and describes it: two hours after receiving an eleventh weekly dose, one subject complained of chest discomfort, an ECG confirmed an acute myocardial infarction, and the subject died approximately one hour later